Penicillamine and Dyspnea - a phase IV clinical study of FDA data

Summary:

Dyspnea is reported as a side effect among people who take Penicillamine (penicillamine), especially for people who are female, 30-39 old, have been taking the drug for 6 - 12 months also take Humira, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Dyspnea when taking Penicillamine. It is created by eHealthMe based on reports of 1,329 people who have side effects when taking Penicillamine from the FDA, and is updated regularly.

What is Penicillamine?

Penicillamine has active ingredients of penicillamine. eHealthMe is studying from 1,329 Penicillamine users. Check the latest studies of Penicillamine.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,717 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

On Aug, 04, 2026

1,329 people reported to have side effects when taking Penicillamine.
Among them, 60 people (4.51%) have Dyspnea.

Among these 60 people:

How long have people been on Penicillamine when they have Dyspnea? *

What is the gender of people who have Dyspnea when taking Penicillamine? *

female: 88.46 %
male: 11.54 %

What is the age of people who have Dyspnea when taking Penicillamine? *

What are other drugs people take besides Penicillamine? *

What are other side effects people have besides Dyspnea? *

Joint Swelling: 43 people, 71.67%
Fatigue (feeling of tiredness): 41 people, 68.33%
Chest Pain: 35 people, 58.33%
Nausea (feeling of having an urge to vomit): 35 people, 58.33%
Diarrhea: 34 people, 56.67%
Pain In Extremity: 34 people, 56.67%
Drug Hypersensitivity: 34 people, 56.67%
Jaw Fracture: 33 people, 55.00%
Joint Pain: 33 people, 55.00%
Elbow Deformity: 33 people, 55.00%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 41 people, 68.33%
Restless Leg Syndrome (a powerful urge to move your legs): 7 people, 11.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 5.00%
High Blood Pressure: 2 people, 3.33%
Diabetes: 2 people, 3.33%
Type 2 Diabetes: 1 person, 1.67%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 1.67%
Skin Ulcer: 1 person, 1.67%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 1.67%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 1 person, 1.67%

* Approximation only. Some reports may have incomplete information.

Do you take Penicillamine and have Dyspnea?

- Check whether Dyspnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Penicillamine:

Penicillamine (1,329 reports)

Dyspnea treatments and more:

Dyspnea (661,578 reports)

Browse all side effects of Penicillamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea:

Dyspnea (3,717 drugs)

Browse all the conditions that are associated with Dyspnea:

Dyspnea (6,067 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on penicillamine (the active ingredients of Penicillamine) and Penicillamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.